|
|
|
Glopink capsule (First to launch in India) |
|
|
Wanbury is the first to launch the concept of benefit of multiple micronutrients in pregnancy. This is a unique formula containing 27 essential micro-nutrients along with 100 mg DHA.
|
|
|
|
P Mute (First to launch in India) |
|
|
Wanbury was first to launch Nabumetone in 1000 mg strength – which is actually the recommended dose. Other brands in the market had low strength.
|
|
|
|
Osteocerin (First to launch in India) |
|
|
Wanbury was first in the market to launch this novel composition. Other brands in the market only had either Diacerein or Glucosamine. |
|
|
|
Traceta Tablet (Early mover) |
|
|
Wanbury was amongst the earliest movers in the market for this formulation. |
|
|
|
Thrombostat (First to launch in India) |
|
|
Wanbury was the first to launch this strength of Enoxaparin (30 mg per 0.3 ml) in the Indian market. |
|
|
|
Etosafe ER Tablet (First to launch in India) |
|
|
Wanbury was the first to launch Etodolac in extended release form in the right strength (600 mg). |
|
|
|
Menaq Tablet (Early mover) |
|
|
Wanbury was one of the early movers in the Indian market to launch this product. |
|
|
|
Nitrofur SR tablet (First to launch in India) |
|
|
Wanbury was first to launch this unique formulation of Nitrofurantoin in Indian market. |
|
|
|
LorQRS Tablet (First to launch in India)
LorQRS - 4 Tablet (First to launch in India) |
|
|
Wanbury was first to launch Lornoxicam in quick release formulation in the Indian market. |
|
|
|
Wellbone Infusion (Early mover) |
|
|
Wanbury was an early mover in this formulation in the Indian market. |
|
|
|
LorQRS - P Tablet (First to launch in India) |
|
|
Wanbury was first to launch combination of Lornoxicam in quick release formulation along with Paracetamol in the Indian market. |
|
|
|
Lortrio Tablet (First to launch in India) |
|
|
Wanbury was first to launch this unique formulation of Nitrofurantoin in Indian market. |
|
|
|
Singlor Tablet (First to launch in India) |
|
|
Wanbury was first to launch Lornoxicam in a combination of immediate and sustained release in the Indian market.
|
|
|
|
LorQRS- T Tablet (First to launch in India) |
|
|
Wanbury was first to launch Lornoxicam in quick release formulation in combination with Thiocolchicoside in the Indian market. |
|
|
|
Bonefit Capsules (First to launch in India) |
|
|
Wanbury was first to launch this unique combination with ingredients like Green tea extract, Lutein, Zeaxanthin in the Indian market. |
|
|
|
D- Infla Gel (Different combination compared to competition)
|
|
|
Wanbury has recently launched this unique diclofenac micro-emulsion gel with penetration enhancers, which is different than other diclofenac topical preparations in the market. |
|
|
|
Unito tablet (First to launch in India) |
|
|
Wanbury was first to launch this combination in the Indian market. |
|
|
|
RabiPlus fast (Early mover) |
|
|
Wanbury was one of the early movers in this market |
|
|
Innovations 